From Name:
From Email:
To Name:
To Email:

Optional Message:


Boulder's miRagen licenses microRNA technology

from Daily Camera

Boulder-based miRagen Therapeutics Inc. announced that it has licensed exclusive rights to technology and intellectual property resulting from Germany's University of Frankfurt's efforts in using microRNA 92 as a therapeutic target within the body. Financial terms were not disclosed in the agreement between the privately held miRagen and t2cure, a German biotech that has an existing licensing agreement with the University of Frankfurt regarding miR-92. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063